Health
GE HealthCare drives innovation in theranostics with latest technological advances
CHICAGO, June 21, 2025--At this year’s Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, GE HealthCare is spotlighting the future of precision care with its innovative portfolio of theranostics-enabling solutions designed to help drive clinical and operational excellence. Making its debut, GE HealthCare’s MIM Software introduces LesionID Pro with automated zero-click pre-processingi – an AI-powered innovation to help aid physician decision making and therapy response moni
About this update from Ge Healthcare Technologies Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":6570,"height":2242,"url":"https://media.zenfs.com/en/business-wire.com/6e30f8456a22664519ae6745e0ac6ba8"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Ze70ZAWswoQRpkaf4ds84g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTMyODtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/6e30f8456a22664519ae6745e0ac6ba8","width":960,"height":328},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/0sQLrmxl6BnqK9hBsJgtpA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD04MTg7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/6e30f8456a22664519ae6745e0ac6ba8","width":1200,"height":409}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"GE HealthCare is helping advance clinical and operational excellence in theranostics and molecular imaging through a comprehensive portfolio of AI-powered imaging technologies, radiopharmaceuticals, cyclotrons, chemistry systems, and workflow-optimizing software—designed to support personalized, data-driven care across the entire patient journey.","length":348,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"At #SNMMI25, the company is proud to introduce LesionID™ Pro with automated zero-click pre-processing,i which aims to help physicians minimize manual segmentation required to access patient-specific insights that can play a key role in delivering precision care with confidence.","length":278,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":626,"olType":false},{"type":"text","content":"CHICAGO, June 21, 2025--(BUSINESS WIRE)--At this year’s Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, GE HealthCare is spotlighting the future of precision care with its innovative portfolio of theranostics-enabling solutions designed to help drive clinical and operational excellence. Making its debut, GE HealthCare’s MIM Software introduces LesionID Pro with automated zero-click pre-processingi – an AI-powered innovation to help aid physician decision making and therapy response monitoring.","length":524,"tagName":"p"},{"type":"text","content":"With cancer accounting for over 10 million deaths globally each year,ii the rise of precision care – particularly theranostics – is offering new hope to patients. By combin...